Literature DB >> 21424744

Bone structural components regulating sites of tumor metastasis.

Julie A Sterling1, Scott A Guelcher.   

Abstract

Tumors such as breast, lung, and prostate frequently metastasize to bone, where they can cause intractable pain and increase the risk of fracture in patients. When tumor cells metastasize to bone, they interact with the microenvironment to promote bone destruction primarily through the secretion of osteolytic factors by the tumor cells and the subsequent release of growth factors from the bone. Our recent data suggest that the differential rigidity of the mineralized bone microenvironment relative to that of soft tissue regulates the expression of osteolytic factors by the tumor cells. The concept that matrix rigidity regulates tumor growth is well established in solid breast tumors, where increased rigidity stimulates tumor cell invasion and metastasis. Our studies have indicated that a transforming growth factor-β (TGF-β) and Rho-associated kinase (ROCK)-dependent mechanism is involved in the response of metastatic tumor cells to the rigid mineralized bone matrix. In this review, we will discuss the interactions between ROCK and TGF-β signaling, as well as potential new therapies that target these pathways.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21424744      PMCID: PMC3430076          DOI: 10.1007/s11914-011-0052-5

Source DB:  PubMed          Journal:  Curr Osteoporos Rep        ISSN: 1544-1873            Impact factor:   5.096


  49 in total

1.  Localization of parathyroid hormone-related protein in breast cancer metastases: increased incidence in bone compared with other sites.

Authors:  G J Powell; J Southby; J A Danks; R G Stillwell; J A Hayman; M A Henderson; R C Bennett; T J Martin
Journal:  Cancer Res       Date:  1991-06-01       Impact factor: 12.701

Review 2.  The tension mounts: mechanics meets morphogenesis and malignancy.

Authors:  Matthew J Paszek; Valerie M Weaver
Journal:  J Mammary Gland Biol Neoplasia       Date:  2004-10       Impact factor: 2.673

3.  Tensional homeostasis and the malignant phenotype.

Authors:  Matthew J Paszek; Nastaran Zahir; Kandice R Johnson; Johnathon N Lakins; Gabriela I Rozenberg; Amit Gefen; Cynthia A Reinhart-King; Susan S Margulies; Micah Dembo; David Boettiger; Daniel A Hammer; Valerie M Weaver
Journal:  Cancer Cell       Date:  2005-09       Impact factor: 31.743

4.  Role of Rho/ROCK and p38 MAP kinase pathways in transforming growth factor-beta-mediated Smad-dependent growth inhibition of human breast carcinoma cells in vivo.

Authors:  Anil K Kamaraju; Anita B Roberts
Journal:  J Biol Chem       Date:  2004-11-01       Impact factor: 5.157

5.  Evidence for a causal role of parathyroid hormone-related protein in the pathogenesis of human breast cancer-mediated osteolysis.

Authors:  T A Guise; J J Yin; S D Taylor; Y Kumagai; M Dallas; B F Boyce; T Yoneda; G R Mundy
Journal:  J Clin Invest       Date:  1996-10-01       Impact factor: 14.808

Review 6.  Mechanisms of bone metastasis.

Authors:  G R Mundy
Journal:  Cancer       Date:  1997-10-15       Impact factor: 6.860

7.  Mechanical stimuli induce vascular parathyroid hormone-related protein gene expression in vivo and in vitro.

Authors:  C J Pirola; H M Wang; M I Strgacich; A Kamyar; B Cercek; J S Forrester; T L Clemens; J A Fagin
Journal:  Endocrinology       Date:  1994-05       Impact factor: 4.736

Review 8.  Defining the roles of parathyroid hormone-related protein in normal physiology.

Authors:  W M Philbrick; J J Wysolmerski; S Galbraith; E Holt; J J Orloff; K H Yang; R C Vasavada; E C Weir; A E Broadus; A F Stewart
Journal:  Physiol Rev       Date:  1996-01       Impact factor: 37.312

Review 9.  Inhibition of RANKL as a treatment for osteoporosis: preclinical and early clinical studies.

Authors:  Michael R McClung
Journal:  Curr Osteoporos Rep       Date:  2006-03       Impact factor: 5.096

10.  TGF-beta signaling blockade inhibits PTHrP secretion by breast cancer cells and bone metastases development.

Authors:  J J Yin; K Selander; J M Chirgwin; M Dallas; B G Grubbs; R Wieser; J Massagué; G R Mundy; T A Guise
Journal:  J Clin Invest       Date:  1999-01       Impact factor: 14.808

View more
  16 in total

Review 1.  Molecular alterations that drive breast cancer metastasis to bone.

Authors:  Penelope D Ottewell; Liam O'Donnell; Ingunn Holen
Journal:  Bonekey Rep       Date:  2015-03-18

2.  Three-Dimensional Mechanical Loading Modulates the Osteogenic Response of Mesenchymal Stem Cells to Tumor-Derived Soluble Signals.

Authors:  Maureen E Lynch; Aaron E Chiou; Min Joon Lee; Stephen C Marcott; Praveen V Polamraju; Yeonkyung Lee; Claudia Fischbach
Journal:  Tissue Eng Part A       Date:  2016-08-01       Impact factor: 3.845

3.  Matrix rigidity regulates the transition of tumor cells to a bone-destructive phenotype through integrin β3 and TGF-β receptor type II.

Authors:  Jonathan M Page; Alyssa R Merkel; Nazanin S Ruppender; Ruijing Guo; Ushashi C Dadwal; Shellese Cannonier; Sandip Basu; Scott A Guelcher; Julie A Sterling
Journal:  Biomaterials       Date:  2015-06-16       Impact factor: 12.479

4.  Wnt signaling induces gene expression of factors associated with bone destruction in lung and breast cancer.

Authors:  Rachelle W Johnson; Alyssa R Merkel; Jonathan M Page; Nazanin S Ruppender; Scott A Guelcher; Julie A Sterling
Journal:  Clin Exp Metastasis       Date:  2014-10-31       Impact factor: 5.150

5.  Contribution of bone tissue modulus to breast cancer metastasis to bone.

Authors:  Scott A Guelcher; Julie A Sterling
Journal:  Cancer Microenviron       Date:  2011-07-26

Review 6.  Engineering 3D Models of Tumors and Bone to Understand Tumor-Induced Bone Disease and Improve Treatments.

Authors:  Kristin A Kwakwa; Joseph P Vanderburgh; Scott A Guelcher; Julie A Sterling
Journal:  Curr Osteoporos Rep       Date:  2017-08       Impact factor: 5.096

7.  BMP9 regulates cross-talk between breast cancer cells and bone marrow-derived mesenchymal stem cells.

Authors:  Shaoheng Wan; Yuehong Liu; Yaguang Weng; Wei Wang; Wei Ren; Chang Fei; Yingying Chen; Zhihui Zhang; Ting Wang; Jinshu Wang; Yayun Jiang; Lan Zhou; Tongchuan He; Yan Zhang
Journal:  Cell Oncol (Dordr)       Date:  2014-09-11       Impact factor: 6.730

8.  The Study of Pain in Rats and Mice.

Authors:  Christina M Larson; George L Wilcox; Carolyn A Fairbanks
Journal:  Comp Med       Date:  2019-12-10       Impact factor: 0.982

9.  gp130 Cytokines Activate Novel Signaling Pathways and Alter Bone Dissemination in ER+ Breast Cancer Cells.

Authors:  Tolu Omokehinde; Alec Jotte; Rachelle W Johnson
Journal:  J Bone Miner Res       Date:  2021-09-17       Impact factor: 6.741

10.  Biphasic α2β1 Integrin Expression in Breast Cancer Metastasis to Bone.

Authors:  Milene N O Moritz; Alyssa R Merkel; Ean G Feldman; Heloisa S Selistre-de-Araujo; Julie A Rhoades Sterling
Journal:  Int J Mol Sci       Date:  2021-06-27       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.